Article

Exploring GZMK as a Prognostic Marker and Predictor of Immunotherapy Response in Breast Cancer: Unveiling Novel Insights into Treatment Outcomes

2024-03-05

Abstract excerpt

<title>Abstract</title> <p>Background Granzyme K (GZMK) is an important mediator released by immune cells to eliminate tumor cells and plays crucial roles in inflammation and tumorigenesis. However, the precise role of GZMK in breast cancer and its underlying mechanisms remain poorly understood. Methods Utilizing data from TCGA and GEO databases, along with various analytical approaches including GO, KEGG, GSEA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1429d523-af60-5cb5-963f-478a517d159c
DOI: 10.21203/rs.3.rs-4004163/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring GZMK as a Prognostic Marker and Predictor of Immunotherapy Response in Breast Cancer: Unveiling Novel Insights into Treatment OutcomesDOI 10.21203/rs.3.rs-4004163/v1Read

Comprehensive landscape of the GZM gene family in pan-cancer: Based on large-scale omics research and single-cell sequencing validationSemantic proximity Read

Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.Semantic proximity Read

Comprehensive Analysis of Granzymes and Perforin Family Genes in Pan-CancerSemantic proximity Read

Granzymes expression patterns predict immunotherapy response and identify the heterogeneity of CD8+ T cell subsetsSemantic proximity Read

GOLPH3: a novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancerSemantic proximity Read

Targeting Breast Cancer with a Combination of DNT and LAG3 Checkpoint Blockage and its MechanismSemantic proximity Read

Expression Patterns and Prognostic Model Construction of the Major Histocompatibility Complex-Related Gene Granzyme B in Oral Squamous Cell CarcinomaSemantic proximity Read

Functional genomics for breast cancer drug target discoverySemantic proximity Read

Identification of Lysine lactylation (kla) -related lncRNA signatures using XGBoost to predict prognosis and immune microenvironment in breast cancer patientsSemantic proximity Read

GSDMS are potential therapeutic targets and prognostic biomarkers in breast cancerSemantic proximity Read

Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentialsSemantic proximity Read